Articles Tagged With:
-
Meaningful Use and Measuring Quality
Here's how one health system found effective meaningful use strategies to accurately measure and improve quality.
-
Fear and Loathing in Pill Mill Country
In a race against time, how will America save itself from its prescription pill demons?
-
Prescient Warning Symptoms: A New Target for Sudden Cardiac Death Prevention
Typical cardiac symptoms frequently precede sudden cardiac arrest and are frequently unheeded, but when acted on are associated with decreased mortality.
-
Five-year EVEREST II Results Allay Long-term Safety and Durability Concerns About MitraClip
Although MitraClip patients had higher rates of re-operation in the first year, adverse event rates in the 1- to 5-year range were reassuringly low and were comparable with surgery.
-
Selecting Patients for Statin Primary Prevention
The new vascular disease risk calculator discriminates who will experience a vascular event in the near future better than using a trial entry criteria approach or a hybrid approach.
-
Blood Transfusion in Cardiac Disease Patients
In patients admitted to the ICU with comorbid cardiac disease, the hemoglobin level below which transfusion was associated with lower hospital mortality was < 8-9 g/dL and < 9-10 g/dL if the admitting diagnosis was acute myocardial infarction.
-
Is Sodium Restriction Detrimental in Chronic Heart Failure?
Dietary sodium restriction may have a detrimental effect on outcome in patients with symptomatic chronic heart failure. They stress that a randomized clinical trial is warranted to resolve the issue.
-
Optimal Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke
This study strongly suggests that compared with maintaining patients on aspirin alone, switching to a different antiplatelet agent, or adding a second antiplatelet agent to aspirin may be better in preventing subsequent vascular events in patients who experienced a new ischemic stroke while taking aspirin.
-
Treatment of AVM-related Epilepsy
There is insufficient evidence to recommend invasive AVM management to reduce epileptic seizure frequency, and this will have to be evaluated in a long-term randomized, controlled clinical trial.
-
ICH May Clinically Mimic TIA
In a large retrospective review of 2137 patients with intracerebral hemorrhage, 34 had transient symptoms that could have been misclassified as “transient ischemic attack” if brain imaging had not been performed.